Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

Fleeman, N.Payne, K.Newman, W. G.Howell, S. J.Boland, A.Oyee, J.Martín Saborido, CarlosFernández Santander, AnaDickson, R.2014-03-182014-03-182013Fleeman, N., Payne, K., Newman, W. G., Howell, S. J., Boland, A., Oyee, J., ..., & Dickson, R. (2013). Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen. Personalized Medicine, 10(6), 601-611.http://hdl.handle.net/11268/2129engAre health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifenjournal article10.2217/pme.13.60restricted accessCáncerTratamiento médico